Alzheimer’s monoclonal antibodies fail to deliver meaningful results
Summary
Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.
Description
Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps in current therapeutic approaches.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source